Andrew John Heath

Andrew John Heath, Chief Executive Officer, holds an M.D. and PhD from Sweden’s Gothenburg University. He has both clinical and commercial experience in the pharmaceutical industry. Until 1996, he was responsible for more than 500 sales and marketing professionals at Astra USA. He served as Chief Executive Officer at AeroGen Inc a privately held drug delivery company from 1996 to 1998,joining Therapeutic Antibodies as Chief Executive Officer in March 1998